Latest / Health and life sciences

PolicyHealthUSConfirmed

FDA’s Digital Health Advisory Committee meets on generative AI medical devices

See how this story connects

The FDA’s Digital Health Advisory Committee was scheduled to meet on 20-21 November 2024 to advise on total product lifecycle considerations for generative AI-enabled medical devices. The agenda covered premarket performance evaluation, risk management and postmarket monitoring, and a public docket (FDA-2024-N-3924) stayed open for comments until 21 January 2025.

Why it matters

Developers of generative AI medical tools got FDA’s questions on testing and monitoring such devices in public, with a docket open to their comments.

When
20 Nov 2024
ID
WTA-N-2024-0016
Who
FDA

Summary by wheresthe.ai, from Federal Register notice 2024-21074. Checked against the source on 9 Oct 2026.

Source copy: download the page as saved on 18 Oct 2026 (PDF). Also held by the Internet Archive.

Next stop on this Storyline: Led toFDA proposes a risk framework for generative AI medical devices

Cite this story

WTA-N-2024-0016: “FDA’s Digital Health Advisory Committee meets on generative AI medical devices.” wheresthe.ai, 20 Nov 2024. https://wheresthe.ai/d/us-fda-dhac-generative-ai-devices-meeting-2024-11/ (source: Federal Register notice 2024-21074).

Spotted an error? Email [email protected].